Literature DB >> 25409617

Lung metastasis of pancreatic carcinoma is regulated by TGFβ signaling.

Liqiang Song1, Ping Wang, Yu Tian, De Chang, Kailong Li, Yongna Fan, Jing Shen, Hongzhen Du, Ruifang Mi, Xiaoxia Bian, Xianchao Tang.   

Abstract

The molecular regulation of the lung metastasis of pancreatic carcinoma (PCC) is not completely understood. Here, we show that the levels of phosphorylated SMAD3, ZEB1, ZEB2, Snail1, and Snail2 were significantly higher in PCC with lung metastasis than in PCC without lung metastasis. Overexpression of TGFβ1 enhanced the invasiveness of PCC cells, while inhibition of TGFβ1 decreased the invasiveness of PCC cells, which appeared to be conducted by activated TGFβ receptor signaling-induced upregulation of ZEB1, ZEB2, Snail1, and Snail2, suggesting a process of epithelial-mesenchymal transition (EMT). Taken together, our study provides evidence that TGFβ receptor signaling-induced EMT may be responsible for the increased PCC invasiveness to enhance its lung metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25409617     DOI: 10.1007/s13277-014-2834-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  14 in total

1.  Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas.

Authors:  M Lieber; J Mazzetta; W Nelson-Rees; M Kaplan; G Todaro
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

2.  M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7.

Authors:  Xiangwei Xiao; Iljana Gaffar; Ping Guo; John Wiersch; Shane Fischbach; Lauren Peirish; Zewen Song; Yousef El-Gohary; Krishna Prasadan; Chiyo Shiota; George K Gittes
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

3.  EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation.

Authors:  Helena Kiefel; Sandra Bondong; Marco Pfeifer; Uwe Schirmer; Natalie Erbe-Hoffmann; Heiner Schäfer; Susanne Sebens; Peter Altevogt
Journal:  Carcinogenesis       Date:  2012-07-04       Impact factor: 4.944

4.  TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

Authors:  Kazuhito Naka; Takayuki Hoshii; Teruyuki Muraguchi; Yuko Tadokoro; Takako Ooshio; Yukio Kondo; Shinji Nakao; Noboru Motoyama; Atsushi Hirao
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

Review 5.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

6.  TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.

Authors:  M E Ewen; H K Sluss; L L Whitehouse; D M Livingston
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

Review 7.  The relevance of the TGF-β Paradox to EMT-MET programs.

Authors:  Chevaun D Morrison; Jenny G Parvani; William P Schiemann
Journal:  Cancer Lett       Date:  2013-03-05       Impact factor: 8.679

8.  SnapShot: pancreatic cancer.

Authors:  Haiyong Han; Daniel D Von Hoff
Journal:  Cancer Cell       Date:  2013-03-18       Impact factor: 31.743

9.  miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2.

Authors:  Yosuke Harazono; Tomoki Muramatsu; Hironori Endo; Narikazu Uzawa; Tatsuyuki Kawano; Kiyoshi Harada; Johji Inazawa; Ken-ichi Kozaki
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

10.  TGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferation.

Authors:  Xiangwei Xiao; John Wiersch; Yousef El-Gohary; Ping Guo; Krishna Prasadan; Jose Paredes; Carey Welsh; Chiyo Shiota; George K Gittes
Journal:  Diabetes       Date:  2012-12-17       Impact factor: 9.461

View more
  2 in total

1.  An Automated High-throughput Array Microscope for Cancer Cell Mechanics.

Authors:  Jeremy A Cribb; Lukas D Osborne; Kellie Beicker; Matthew Psioda; Jian Chen; E Timothy O'Brien; Russell M Taylor Ii; Leandra Vicci; Joe Ping-Lin Hsiao; Chong Shao; Michael Falvo; Joseph G Ibrahim; Kris C Wood; Gerard C Blobe; Richard Superfine
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

2.  ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer.

Authors:  Armen Gharibi; Sa La Kim; Justin Molnar; Daniel Brambilla; Yvess Adamian; Malachia Hoover; Julie Hong; Joy Lin; Laurelin Wolfenden; Jonathan A Kelber
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.